EFFECTS OF GRADED DOSES OF VASOPRESSIN ON MEDIAN FIBRILLATION FREQUENCY IN A PORCINE MODEL OF CARDIOPULMONARY-RESUSCITATION - RESULTS OF A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL

Citation
Hu. Strohmenger et al., EFFECTS OF GRADED DOSES OF VASOPRESSIN ON MEDIAN FIBRILLATION FREQUENCY IN A PORCINE MODEL OF CARDIOPULMONARY-RESUSCITATION - RESULTS OF A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL, Critical care medicine, 24(8), 1996, pp. 1360-1365
Citations number
36
Categorie Soggetti
Emergency Medicine & Critical Care
Journal title
ISSN journal
00903493
Volume
24
Issue
8
Year of publication
1996
Pages
1360 - 1365
Database
ISI
SICI code
0090-3493(1996)24:8<1360:EOGDOV>2.0.ZU;2-8
Abstract
Objective: To assess the effects of graded doses of vasopressin vs. sa line on median fibrillation frequency a nd defibrillation success in a porcine model of cardiopulmonary resuscitation. Design: Prospective, randomized, controlled trial. Setting: Animal laboratory in a universi ty medical center. Subjects: Twenty-eight domestic pigs (body weight b etween 26 and 31 kg), aged 12 to 14 wks. Interventions and Main Result s: After 4 mins of ventricular fibrillation and 3 mins of closed-chest cardiopulmonary resuscitation, the animals were allocated to receive either 0.2 U/kg of vasopressin (n = 7), 0.4 U/kg of vasopressin (n = 7 ), 0.8 U/kg of vasopressin (n = 7), or 10 mL of saline (n = 7, control group). Using radiolabeled microspheres, myocardial blood flow rates during cardiopulmonary resuscitation-before drug administration and 90 secs and 5 mins after drug administration-were as follows in the four groups (mean +/- SEM): 18.8 +/- 0.9, 17.2 +/- 1.1, and 14.6 +/- 1.4 m L/min/100 g in the control group; 17.8 +/- 2.2, 49.6 +/- 6.3 (p <.01 v s. control group), and 29.4 +/- 3.1 mL/min/100 g (p <.05 vs. central g roup) in the group receiving 0.2 U/kg of vasopressin; 17.1 +/- 1.0, 52 .4 +/- 7.5 (p <.01 vs, control group), and 52.2 +/- 5.8 mL/min/100 g ( p <.001 vs, control group) in the group receiving 0.4 U/kg of vasopres sin; and 18.1 +/- 1.6, 94.9 +/- 9.2 (p <.001 vs. control group), and 5 7.2 +/- 6.3 mL/min/100 g (p <.001 vs. control group) in the group rece iving 0.8 U/kg of vasopressin. Using spectral analysis, median frequen cies of ventricular fibrillation-before drug administration and 90 sec s and 5 mins after drug administration-were as follows in the four gro ups: 9.6 +/- 0.4, 8.5 +/- 0.8, and 7.2 +/- 1.0 Hz in the control group ; 9.7 +/- 0.5, 12.9 +/- 0.8 (p <.01 vs. control group), and 12.7 +/- 0 .8 Hz (p <.001 vs. control group) in the group receiving 0.2 U/kg of v asopressin; 10.3 +/- 0.2, 12.7 +/- 0.9 (p <.01 vs. control group), and 12.8 +/- 0.7 Hz (p <.001 vs. control group) in the group receiving 0. 4 U/kg of vasopressin; and 10.0 +/- 0.9, 14.1 +/- 0.9 (p < .001 vs, co ntrol group), and 12.5 +/- 0.9 Hz (p <.001 vs. control group) in the g roup receiving 0.8 U/kg of vasopressin at the same points in time. Med ian frequency before the first defibrillation attempt was 12.3 +/- 0.4 Hz in the resuscitated animals (n = 19) and 8.2 +/- 1.2 Hz in the non resuscitated animals (n = 9) (p <.001).Conclusions: This study contrib utes to the characterization of the effect of increasing global myocar dial blood flow on median fibrillation frequency after administration of graded doses of vasopressin in a porcine model of ventricular fibri llation. Interventions such as vasopressor treatment that increase fib rillation frequency improve the chance of successful defibrillation.